Results 241 to 250 of about 16,343,665 (315)
Virtual Screening and Testing of GSK-3 Inhibitors Using Human SH-SY5Y Cells Expressing Tau Folding Reporter and Mouse Hippocampal Primary Culture under Tau Cytotoxicity. [PDF]
Lin CH+12 more
europepmc +1 more source
Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015)
V. Palomo, Ana Martínez
semanticscholar +1 more source
Kidney injury in heart failure‐related cardiogenic shock. AKI, acute kidney injury; CI, confidence interval; eCPR, extracorporeal cardiopulmonary resuscitation; eGFR, estimated glomerular filtration rate; HR, hazard ratio; OR, odds ratio; VA‐ECMO, veno‐arterial extracorporeal membrane oxygenation.
Jonas Sundermeyer+41 more
wiley +1 more source
Xiaotangzhike Pill Attenuates the Progression of Diabetes In Vivo through the Mediation of the Akt/GSK-3β Axis. [PDF]
Yang L+5 more
europepmc +1 more source
The Mck1 GSK-3 kinase inhibits the activity of Clb2-Cdk1 post-nuclear division [PDF]
Jennifer McQueen+4 more
openalex +1 more source
Streamlining Vorinostat Synthesis: A Chemoenzymatic Continuous Flow Approach
A chemoenzymatic protocol for the synthesis of histone deacetylase inhibitor vorinostat has been established. Immobilized lipase from C. antarctica (imm‐CaLB) allowed the functionalization of suberanoyl acid 1 and further conversion to vorinostat via ion‐exchange resin treatment.
Francesca Annunziata+6 more
wiley +1 more source
Regulatory Functions of Nilaparvata lugens GSK-3 in Energy and Chitin Metabolism. [PDF]
Ding YJ+6 more
europepmc +1 more source
GSK-3: A Bifunctional Role in Cell Death Pathways [PDF]
Keith M. Jacobs+5 more
openalex +1 more source
Abstract Quantitative risk assessments of chemicals are routinely performed using in vivo data from rodents; however, there is growing recognition that non‐animal approaches can be human‐relevant alternatives. There is an urgent need to build confidence in non‐animal alternatives given the international support to reduce the use of animals in toxicity ...
Marc A. Beal+14 more
wiley +1 more source